Related Experiment Video

Updated: Aug 15, 2026

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

Mutation load, functional overlap, and synthetic lethality in the evolution and treatment of cancer

Alexander Kamb1

  • 1Deltagen Proteomics, Inc., 615 Arapeen Drive, Suite 300, Salt Lake City, UT 84108, USA. akamb@deltagenpro.com

Journal of Theoretical Biology
|June 20, 2003
PubMed

Insights

Cancer drug effectiveness may stem from combined mutations, not just cell cycles. Targeting complex cellular processes with genetic overlaps offers new therapeutic strategies for cancer treatment.

Area of Science:

  • Oncology
  • Genetics
  • Pharmacology

Background:

  • Conventional anti-cancer drug efficacy is unclear due to widespread target distribution and essential functions.
  • Cell cycle differences alone do not fully explain why some cancer cells respond to chemotherapy.

Purpose of the Study:

  • To propose a novel model explaining cancer cell drug sensitivity.
  • To explore the role of combinatorial mutations in therapeutic outcomes.
  • To identify new drug target opportunities in cancer treatment.

Main Methods:

  • Conceptual modeling integrating synthetic-lethal interactions and mutation loads.
  • Analysis of genetic redundancy and overlapping cellular processes in cancer.

Main Results:

  • A model suggesting that combined mutations in cancer cells contribute to drug sensitivity.
  • Identification of complex cellular processes involving genetically redundant components as potential drug targets.

Conclusions:

  • Cancer cell drug sensitivity can be explained by combinatorial effects of mutations.
  • Targeting complex pathways like DNA replication and chromosome segregation presents promising therapeutic avenues.

More Related Videos

Pooled shRNA Library Screening to Identify Factors that Modulate a Drug Resistance Phenotype14:51

Pooled shRNA Library Screening to Identify Factors that Modulate a Drug Resistance Phenotype

Published on: June 17, 2022

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells07:23

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells

Published on: May 30, 2025

Related Concept Videos

Mismatch Repair01:36

Mismatch Repair

Overview
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Mismatch Repair01:20

Mismatch Repair

Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...